Ovarian Screening Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2001-06-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are:

* To identify women at increased risk for developing ovarian cancer
* To detect ovarian cancers at an early stage
* To investigate the role of tumor membrane fragments as tumor markers for early ovarian carcinoma

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

NCT04794322

Ovarian Neoplasms Ovarian Epithelial Carcinoma Fallopian Tube Neoplasms +12 more

RECRUITING

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

NCT00043472

Breast Cancer Ovarian Cancer

COMPLETED

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

NCT00626873

Ovarian Cancer

COMPLETED PHASE1

Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer

NCT00039559

Ovarian Cancer

UNKNOWN NA

Risk of Ovarian Cancer in Patients With a Pelvic Mass

NCT00315692

Ovarian Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the year 2001 approximately 23,400 women in the USA are expected to be diagnosed with ovarian carcinoma and 13,900 will die of the disease. This means that within the USA more women die annually from ovarian cancer than all other gynecologic malignancies combined. Within the Commonwealth of Kentucky approximately 250 women per year develop ovarian carcinoma.

Survival for patients with ovarian cancer is directly related to the stage of disease at diagnosis. Unfortunately, the majority of women present with advanced disease (Stage III and IV) and most of these patients will die of the disease.

The aim of screening for ovarian cancer is to reduce the morbidity and mortality by detecting the disease at an early stage since ovarian cancer detected when disease is confined to the ovary (Stage I) is associated with a dramatically improved 5-year survival. Disease confined to the ovary may be cured in over 90% of patients, in some cases without the need for chemotherapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Asymptomatic women over the age of 45 with one or both ovaries.
* Women over the age of 25 with one or both ovaries and any of the following:

* A personal history of breast, colon or endometrial cancer or breast cancer gene (BRCA) 1 or 2 positive
* First-degree relative (mother, sister, daughter) with ovarian or breast cancer
* Two family members with either breast and/or ovarian cancer
* Mother, sister, daughter, grandparent with a positive BRCA1 or BRCA2 genetic test result.
* Past use of fertility drugs such as Clomid or Pergonal for more than a year.